Ketamine

Recall | Veterinary Medicines | 29/09/2016

In a letter dated 19.09.2016, the marketing authorization holder informed its customers that particles had been detected in some bottles. It cannot be ruled out that bottles on the market are also affected, which is why a recall is being carried out. As the product is a veterinary specialty approved in Germany, it can be placed on the market in Austria within the scope of a transfer notification pursuant to the Austrian Medicinal Products Import Act 2010.

Name of the medicinal product Ketamin 100 mg/ml Injektionslösung
Marketing authorisation number(s) Deutschland: 401650.00.00
Marketing authorisation holder CP Pharma Handelsgesellschaft mbH
Batch number(s) 14D015 und 15I022
Classification of the recallII
BASG reference number INS - 640.001 - 1833
Email

Further inquiry note